Adverse events associated with albendazole and other products used for treatment of giardiasis in dogs
Meyer, E.K.
Journal of the American Veterinary Medical Association 213(1): 44-46
1998
ISSN/ISBN: 0003-1488 PMID: 9656022 Document Number: 487255
Document emailed within 1 workday
Related Documents
Bezruchka, S. 2001: Adverse events in British hospitals. Expanded definition of adverse events is needed Bmj 322(7299): 1427Yongyuth, P.; Koyadun, S.; Jaturabundit, N.; Jariyahuttakij, W.; Bhumiratana, A. 2007: Adverse reactions of 300 MG diethylcarbamazine, and in a combination of 400 MG albendazole, for a mass annual single dose treatment, in migrant workers in Phang Nga province Journal of the Medical Association of Thailand 90(3): 552-563
Supali, T.; Ismid, I.Suhariah.; Rückert, P.; Fischer, P. 2002: Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae Tropical Medicine and International Health: Tm and Ih 7(10): 894-901
Sirivichayakul, C.; Pojjaroen-anant, C.; Wisetsing, P.; Chanthavanich, P.; Praevanit, R.; Limkittikul, K.; Pengsaa, K. 2001: A comparative trial of albendazole alone versus combination of albendazole and praziquantel for treatment of Trichuris trichiura infection Southeast Asian Journal of Tropical Medicine and Public Health 32(2): 297-301
Tsukuda, M. 2002: Prevention and treatment for adverse events induced by chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(7): 1284-1291
Koinuma, N.; Takeyoshi, H. 2003: Economic analysis of adverse events in cancer treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 61(6): 1030-1038
Homma, M. 1992: Adverse events and adverse reactions associated with drugs--important actual spontaneous reporting of the drug event Ryumachi 32(5): 429-431
Lenzi, L.; Wiens, A.; Pontarolo, R. 2013: Evaluation of adverse events associated with antiretroviral therapy and the relationship to treatment adherence International Journal of Clinical Pharmacology and Therapeutics 51(2): 141-146
Bukirwa, H.; Nayiga, S.; Lubanga, R.; Mwebaza, N.; Chandler, C.; Hopkins, H.; Talisuna, A.O.; Staedke, S.G. 2008: Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events Tropical Medicine and International Health: Tm and Ih 13(9): 1143-1152
Estrada, V.; de Villar, N.; Serrano-Ríos, M. 2001: Cutaneous adverse events related to simultaneous nevirapine treatment and pneumococcal vaccination in HIV-infected patients Medicina Clinica 116(12): 479
Moiseev, S.V.; Novikov, P.I.; Semenkova, E.N.; Strizhakov, L.A.; Gulyaev, S.V.; Yanushkevich, T.N.; Nikiforova, N.V.; Meshkov, A.D.; Panasyuk, V.V.; Sokorin, Y.D.; Taranova, M.V.; Parfenova, S.A.; Dubrovskaya, L.V.; Zhabina, E.S.; Kuznetsova, E.I.; Lopatina, I.A.; Bulanov, N.M.; Mukhin, N.A. 2013: Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases Terapevticheskii Arkhiv 85(5): 37-43
Shore, N.D.; Sieber, P.; Schimke, L.; Perzin, A.; Olsen, S. 2013: Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer Urologic Nursing 33(5): 236-44 248
Gold, M.H.; Biron, J. 2006: A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy Journal of Drugs in Dermatology: Jdd 5(8): 796-798
Tienboon, P.; Jaruwangsanti, N. 2014: A prospective analytical study of the effects and adverse events of alendronate (Aldren70) treatment in Thai postmenopausal women Journal of the Medical Association of Thailand 97(6): 621-628
Li, S.L.; Gao, X.P.; Chen, Q.Q.; Fu, X.H.; Zhao, Y.; Duan, J.M.; Tang, Y.Q.; Sun, J.; Li, J.L.; Zhou, Q.M. 2020: Retrospectively analysis of characteristics and risk factors of immune treatment-related hepatic adverse events in malignant tumor Zhonghua Zhong Liu Za Zhi 42(1): 50-54
Beasley, C.M.; Nilsson, M.E.; Koke, S.C.; Gonzales, J.S. 2000: Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose Journal of Clinical Psychiatry 61(10): 722-728
Turon-Estrada, A.; López-Pousa, S.; Gelada-Batlle, E.; Garre-Olmo, J.; Lozano-Gallego, M.; Hernández-Ferràndiz, M.; Fajardo-Tibau, C.; Morante-Muñoz, V.; Vilalta-Franch, J. 2003: Tolerance and adverse events of treatment with acetylcholinesterase inhibitors in a clinical sample of patients with very slight and mild Alzheimer s disease over a six-month period Revista de Neurologia 36(5): 421-424
Barr, S.C.; Bowman, D.D.; Frongillo, M.F.; Joseph, S.L. 1998: Efficacy of a drug combination of praziquantel, pyrantel pamoate, and febantel against giardiasis in dogs American Journal of Veterinary Research 59(9): 1134-1136
Gerdén, B. 2005: The Medical Products Agency about SSRi to pregnant women and adverse effects on the fetus. Long-term adverse effects are not proved, documentation is insufficient, more research is necessary Lakartidningen 102(10): 791
Redondo, P.A.; Alvarez, A.I.; Garcia, J.L.; Larrodé, O.M.; Merino, G.; Prieto, J.G. 1999: Presystemic metabolism of albendazole: experimental evidence of an efflux process of albendazole sulfoxide to intestinal lumen Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(6): 736-740